Empirical Finance’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.38M | Buy |
50,059
+338
| +0.7% | +$36.3K | 0.28% | 70 |
|
|
2025
Q1 | $5.02M | Buy |
49,721
+701
| +1% | +$70.7K | 0.3% | 66 |
|
|
2024
Q4 | $4.38M | Sell |
49,020
-619
| -1% | -$55.3K | 0.25% | 77 |
|
|
2024
Q3 | $4.16M | Buy |
49,639
+1,254
| +3% | +$105K | 0.24% | 80 |
|
|
2024
Q2 | $3.73M | Sell |
48,385
-2,895
| -6% | -$223K | 0.23% | 86 |
|
|
2024
Q1 | $3.51M | Buy |
51,280
+1,786
| +4% | +$122K | 0.22% | 103 |
|
|
2023
Q4 | $2.86M | Buy |
49,494
+401
| +0.8% | +$23.2K | 0.2% | 106 |
|
|
2023
Q3 | $2.59M | Buy |
49,093
+4,665
| +11% | +$246K | 0.19% | 109 |
|
|
2023
Q2 | $2.4M | Buy |
44,428
+4,843
| +12% | +$262K | 0.19% | 108 |
|
|
2023
Q1 | $1.98M | Buy |
39,585
+2,136
| +6% | +$107K | 0.19% | 114 |
|
|
2022
Q4 | $1.73M | Buy |
37,449
+2,989
| +9% | +$138K | 0.18% | 123 |
|
|
2022
Q3 | $1.34M | Buy |
34,460
+5,706
| +20% | +$221K | 0.16% | 130 |
|
|
2022
Q2 | $1.07M | Buy |
28,754
+1,536
| +6% | +$57.3K | 0.14% | 142 |
|
|
2022
Q1 | $1.21M | Buy |
27,218
+2,963
| +12% | +$131K | 0.14% | 136 |
|
|
2021
Q4 | $1.03M | Buy |
24,255
+6,527
| +37% | +$277K | 0.12% | 145 |
|
|
2021
Q3 | $769K | Buy |
17,728
+1,027
| +6% | +$44.5K | 0.12% | 178 |
|
|
2021
Q2 | $714K | Buy |
16,701
+2,206
| +15% | +$94.3K | 0.12% | 201 |
|
|
2021
Q1 | $521K | Hold |
14,495
| – | – | 0.09% | 197 |
|
|
2020
Q4 | $521K | Buy |
14,495
+2,564
| +21% | +$92.2K | 0.09% | 197 |
|
|
2020
Q3 | $456K | Buy |
11,931
+2,770
| +30% | +$106K | 0.1% | 184 |
|
|
2020
Q2 | $322K | Buy |
9,161
+1,145
| +14% | +$40.2K | 0.08% | 193 |
|
|
2020
Q1 | $262K | Buy |
8,016
+2,887
| +56% | +$94.4K | 0.08% | 173 |
|
|
2019
Q4 | $232K | Buy |
+5,129
| New | +$232K | 0.06% | 189 |
|
|
2017
Q1 | – | Sell |
-583
| Closed | -$13K | – | 152 |
|
|
2016
Q4 | $13K | Buy |
+583
| New | +$13K | 0.01% | 307 |
|